The Challenges One of the greatest challenges across the biologics development lifecycle is the race to deliver novel, high quality therapeutics to patients, faster and more cost effectively. Balancing the specificity, speed, and cost is tough—and that’s before you consider a further factor: Alongside the constant pressure to innovate, companies must also meet exacting standards…